Page last updated: 2024-08-26

arsenic and Hepatitis C, Chronic

arsenic has been researched along with Hepatitis C, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CJ; Chen, CL; Chiou, HY; Hsieh, FI; Hsu, KH; Hsu, LI; Liu, CT; Wang, YH; Wen-Juei Jeng, R; Wu, MM; Yang, TY1
Yu, MC; Yuan, JM1
Bakulin, IG; Ivanova, MA; Novozhenov, VG1

Reviews

1 review(s) available for arsenic and Hepatitis C, Chronic

ArticleYear
Environmental factors and risk for hepatocellular carcinoma.
    Gastroenterology, 2004, Volume: 127, Issue:5 Suppl 1

    Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Diabetes Complications; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Obesity; Risk Factors; Smoking

2004

Other Studies

2 other study(ies) available for arsenic and Hepatitis C, Chronic

ArticleYear
Effects of Arsenic in Drinking Water on Risk of Hepatitis or Cirrhosis in Persons With and Without Chronic Viral Hepatitis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:9

    Topics: Aged; Arsenicals; DNA, Viral; Drinking Water; Female; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Risk Assessment; Taiwan

2016
[The possibilities of element status evaluation in determination of antiviral therapy resistance in patients with chronic hepatitis C].
    Voenno-meditsinskii zhurnal, 2006, Volume: 327, Issue:8

    Topics: Adult; Antiviral Agents; Arsenic; Case-Control Studies; Drug Resistance, Viral; Drug Therapy, Combination; Elements; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Metals; Middle Aged; Phosphorus; Recombinant Proteins; Treatment Outcome

2006